Eledon Pharmaceuticals, Inc. (ELDN)

CIK 1404281 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Eledon Pharmaceuticals, Inc..

Recent SEC filings

FiledFormAccession number
Sep 4, 2026S-80001193125-26-383824
Aug 13, 20268-K0001193125-26-349170
Aug 13, 202610-Q0001193125-26-349314
Aug 4, 202640001193125-26-333133
Aug 4, 202640001193125-26-333136
Jul 31, 2026SCHEDULE 13G0002100119-26-001370
Jun 22, 20268-K0001193125-26-277653
May 15, 2026SCHEDULE 13G/A0000921895-26-001390
May 13, 202610-Q0001193125-26-221702
May 13, 20268-K0001193125-26-221658
May 11, 2026EFFECT9999999995-26-001576
May 1, 2026S-30001193125-26-201426
Apr 30, 2026DEF 14A0001193125-26-197732
Apr 30, 2026ARS0001193125-26-197765
Apr 30, 2026DEFA14A0001193125-26-197775
Apr 27, 2026SCHEDULE 13G0002012383-26-001685
Apr 21, 2026PRE 14A0001193125-26-164367
Mar 26, 2026SCHEDULE 13G/A0000102909-26-001125
Mar 19, 20268-K0001193125-26-116154
Mar 19, 202610-K0001193125-26-116164
Feb 17, 2026SCHEDULE 13G/A0001346824-26-000041
Feb 13, 2026SCHEDULE 13G/A0001104659-26-015219
Jan 21, 2026SCHEDULE 13G/A0002012383-26-000664
Jan 16, 202640001193125-26-015484
Jan 16, 202640001193125-26-015489